St John's Wort Complementary Therapy for ADHD
A randomized, double-blind, placebo-controlled trial of hypericum perforatum (St John's Wort) in the treatment of attention-deficit/hyperactivity disorder (ADHD) was conducted in 54 children aged 6 to 17 years at Bastyr University, Kenmore, WA.
Saved in:
Main Author: | J Gordon Millichap (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2008-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
St. John's Wort for Major Depressive Disorder A Systematic Review
by: Ruelaz Maher, Alicia
Published: (2015) -
St. John\'s wort (Hypericum perforatum L.): A Review
by: H Naghdi Badi, et al.
Published: (2005) -
NMDA Receptor-Antagonistic Properties of Hyperforin, a Constituent of St. John's Wort
by: Vikas Kumar, et al.
Published: (2006) -
Clinically relevant safety issues associated with St. John's wort product labels
by: Rutledge Jennifer C, et al.
Published: (2008) -
PKC-Mediated Potentiation of Morphine Analgesia by St. John's Wort in Rodents and Humans
by: Nicoletta Galeotti, et al.
Published: (2014)